# Review 08 Reflection And Action Plan

Last updated: 2026-05-25

This review keeps the project in Phase 1 dry-run and Phase 2 documentation/preparation only. It does not authorize Phase 2 paper-mode implementation, broker execution, or live trading.

Source review artifact: `C:\Users\ZHAO ZHU INFORMATION\Downloads\FINAL_REPO_REVIEW_AFTER_REPO_UPDATE_2026_05_25.md`

## Reviewer Decision

| Area | Decision |
| --- | --- |
| Continue Phase 1 dry-run | GO |
| Continue passive spread logging | GO |
| Continue Phase 2 documentation/prep | GO |
| Start Phase 2 paper implementation | NO-GO |
| Enable paper fills | NO-GO |
| Add broker execution/live trading | NO-GO |

## Current Phase Boundary

| Boundary | Policy |
| --- | --- |
| Active phase | Phase 1 dry-run shell. |
| Trade permission | Must remain `false`. |
| Runtime mode | Must remain dry-run only. |
| Phase 2 status | Preparation only until every objective gate passes. |
| Live trading | Absolute no-go. |

## Critical Blockers

| Blocker | Current requirement |
| --- | --- |
| Five trading-day soak | `observed_days >= 5`. |
| Active-market streak | 72h uninterrupted active-market M5 continuity. Weekend, stale, and market-closed rows break the streak. |
| Process/code-freeze gate | 96h process uptime and 96h code-freeze marker age. |
| Measured cost model | `MEASURED_COST_MODEL.md = PASS` after at least 5 observed spread days. |
| Measured-cost revalidation | `BREAKOUT_RETEST_MEASURED_COST_REVALIDATION.md = PASS`. |
| Phase 1 acceptance | `PHASE1_ACCEPTANCE_REPORT.md = PASS`. |
| Phase 1 review index | `PHASE1_REVIEW_INDEX.md = PASS`. |
| VPS selection | Owner/provider decision recorded as PASS. |
| Owner approval | `PHASE2_OWNER_APPROVAL.md = PASS`, only after objective gates pass. |

## Risk Notes

| Risk | Review response |
| --- | --- |
| Measured costs may erase the edge | Keep passive spread logging running until 5 observed days, then let measured-cost revalidation decide. Do not infer from partial data. |
| Single-edge family concentration | First Phase 2 paper stream, if later authorized, is `breakout_retest` only. Same-family variants are observer-only. |
| Code-freeze reset risk | Avoid active Phase 1 EA code, schema, routing, risk, execution, or logger-behavior changes unless a critical bug is present. |

## Allowed Work During Soak

| Work type | Status |
| --- | --- |
| Regenerate reports from existing logs | Allowed. |
| Improve report readability without runtime schema changes | Allowed. |
| Update documentation and review artifacts | Allowed. |
| Add offline analysis around measured spread logs | Allowed. |
| Add tests for report generators | Allowed if they do not affect runtime. |
| Verify `status.html` generation | Allowed. |

## Avoid During Soak

| Work type | Status |
| --- | --- |
| Modify `Phase1DryRunShell.mq5` | Avoid unless critical bug. |
| Add broker-side execution code | Not allowed. |
| Add `CTrade`, `OrderSend`, `OrderSendAsync`, `trade.Buy`, `trade.Sell`, `PositionOpen`, or `PositionModify` | Not allowed. |
| Change `decision_log.csv` schema | Not allowed without explicit approval. |
| Add new active observers to the running shell | Not allowed during soak. |
| Change router/risk/execution guard thresholds | Not allowed. |
| Restart MT5 for non-critical repo changes | Avoid. |

## Required Future Artifacts

These are future gates, not current authorizations:

| Artifact | Required status |
| --- | --- |
| `PHASE1_ACCEPTANCE_REPORT.md` | PASS |
| `PHASE1_REVIEW_INDEX.md` | PASS |
| `PHASE2_READINESS_REPORT.md` | PASS |
| `MEASURED_COST_MODEL.md` | PASS |
| `BREAKOUT_RETEST_MEASURED_COST_REVALIDATION.md` | PASS |
| `PHASE2_OWNER_APPROVAL.md` | PASS |
| `PHASE2_PAPER_MODE_IMPLEMENTATION_SPEC.md` | Present after authorization |
| `PHASE2_PAPER_LEDGER_SCHEMA_REPORT.md` | PASS after authorization |

## Immediate Next Work

1. Keep Phase 1 dry-run running.
2. Keep passive spread logger running.
3. Let the 72h active-market, 96h code-freeze, and 5 trading-day soak gates mature without non-critical runtime changes.
4. Regenerate status and readiness artifacts through periodic checks.
5. When measured spread evidence reaches 5 observed days, regenerate measured cost and measured-cost revalidation reports.
6. If measured net expectancy after cost falls below `+0.15R`, suspend the breakout-retest family and return to research.
